Human papillomavirus reporting: Impact on Bethesda cytology reports

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 8, 2003, Pages 969-972

  Raab, Stephen S ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ASSAY; CONFERENCE PAPER; DIAGNOSTIC TEST; DNA DETERMINATION; DNA HYBRIDIZATION; LABORATORY TEST; LIGASE CHAIN REACTION; NOMENCLATURE; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PROBABILITY; RISK ASSESSMENT; SOUTHERN BLOTTING; SQUAMOUS CELL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS DIAGNOSIS; WART VIRUS; ARTICLE; CLASSIFICATION; CYTODIAGNOSIS; FEMALE; HUMAN; INFORMATION SYSTEM; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; PATHOLOGY; STANDARD; UNITED STATES; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

CYTODIAGNOSIS; FEMALE; HUMANS; INFORMATION SYSTEMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRACTICE GUIDELINES; TUMOR VIRUS INFECTIONS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0041673349     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119.
2. Powsner SM, Costa J, Homer RJ. Clinicians are from Mars and pathologists are from Venus. Arch Pathol Lab Med. 2000;124:1040-1046.
3. Leslie KO, Rosai J. Standardization of the surgical pathology report: formats, templates, and synoptic reports. Semin Diagn Pathol. 1994;11:253-257.
4. Wyatt JC, Wright P. Design should help use of patients' data. Lancet. 1998; 352:1375-1378.
5. Nygren E, Wyatt JC, Wright P. Helping clinicians to find data and avoid delays. Lancet. 1998;352:1462-1466.
6. Zarbo RJ. The oncologic pathology report: quality by design. Arch Pathol Lab Med. 2000;124:1004-1010.
7. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. JAMA. 1989;262:931-934.
8. The 1991 Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda Workshop. JAMA. 1992;267:1892.
9. Davey D, Woodhouse S, Styer P, Stastny J, Mody D. Atypical epithelial cells and specimen adequacy: current laboratory practices of participants in the College of American Pathologists interlaboratory comparison program in cervicovaginal cytology. Arch Pathol Lab Med. 2000;124:203-211.
10. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus Guidelines for the management of women with cervical cytologic abnormalities. JAMA. 2002;287:2120-2129.
11. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst. 2000;92:397-402.
12. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93:293-299.
13. Bergeron C, Jeannel D, Poveda JD, Cassonet P, Orth G. Human papillomavirus testing in women with mild cytologic atypia. Obstet Gynecol. 2000;95: 821-827.
14. Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia: using human papillomavirus testing for equivocal Papanicolaou results. JAMA. 1999;281:1605-1610.
15. Ronnett BM, Manos MM, Ransley JE, et al. Atypical glandular cells of undetermined significance: cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol. 1999;30:816-825.